Cargando…

Distinct and shared neuropsychiatric phenotypes in FTLD-tauopathies

Frontotemporal lobar degeneration (FTLD) with tau pathology (FTLD-tau) commonly causes dementia syndromes that include primary progressive aphasia (PPA) and behavioral variant frontotemporal dementia (bvFTD). Cognitive decline in PPA and bvFTD is often accompanied by debilitating neuropsychiatric sy...

Descripción completa

Detalles Bibliográficos
Autores principales: Keszycki, Rachel, Kawles, Allegra, Minogue, Grace, Zouridakis, Antonia, Macomber, Alyssa, Gill, Nathan, Vu, My, Zhang, Hui, Coventry, Christina, Rogalski, Emily, Weintraub, Sandra, Mesulam, M-Marsel, Geula, Changiz, Gefen, Tamar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10289868/
https://www.ncbi.nlm.nih.gov/pubmed/37358954
http://dx.doi.org/10.3389/fnagi.2023.1164581
_version_ 1785062372328603648
author Keszycki, Rachel
Kawles, Allegra
Minogue, Grace
Zouridakis, Antonia
Macomber, Alyssa
Gill, Nathan
Vu, My
Zhang, Hui
Coventry, Christina
Rogalski, Emily
Weintraub, Sandra
Mesulam, M-Marsel
Geula, Changiz
Gefen, Tamar
author_facet Keszycki, Rachel
Kawles, Allegra
Minogue, Grace
Zouridakis, Antonia
Macomber, Alyssa
Gill, Nathan
Vu, My
Zhang, Hui
Coventry, Christina
Rogalski, Emily
Weintraub, Sandra
Mesulam, M-Marsel
Geula, Changiz
Gefen, Tamar
author_sort Keszycki, Rachel
collection PubMed
description Frontotemporal lobar degeneration (FTLD) with tau pathology (FTLD-tau) commonly causes dementia syndromes that include primary progressive aphasia (PPA) and behavioral variant frontotemporal dementia (bvFTD). Cognitive decline in PPA and bvFTD is often accompanied by debilitating neuropsychiatric symptoms. In 44 participants with PPA or bvFTD due to autopsy-confirmed FTLD-tau, we characterized neuropsychiatric symptoms at early and late disease stages and determined whether the presence of certain symptoms predicted a specific underlying FTLD-tauopathy. Participants completed annual research visits at the Northwestern University Alzheimer’s Disease Research Center. All participants had an initial Global Clinical Dementia Rating (CDR) Scale score ≤ 2, and neuropsychiatric symptoms were evaluated via the Neuropsychiatric Inventory-Questionnaire (NPI-Q). We assessed the frequency of neuropsychiatric symptoms across all participants at their initial and final visits and performed logistic regression to determine whether symptoms predicted a specific FTLD-tau pathologic diagnosis. Across the FTLD-tau cohort, irritability and apathy were most frequently endorsed at initial and final visits, respectively, whereas psychosis was highly uncommon at both timepoints. Irritability at initial visit predicted greater odds of a 4-repeat compared to a 3-repeat tauopathy (OR = 3.95, 95% CI = 1.10–15.83, p < 0.05). Initial sleep disturbance predicted greater odds of progressive supranuclear palsy (PSP) compared to other FTLD-tau subtypes (OR = 10.68, 95% CI = 2.05–72.40, p < 0.01). Appetite disturbance at final evaluation predicted lower odds of PSP (OR = 0.15, 95% CI = 0.02–0.74, p < 0.05). Our findings suggest that characterization of neuropsychiatric symptoms can aid in the prediction of underlying FTLD-tauopathies. Given considerable pathologic heterogeneity underlying dementias, neuropsychiatric symptoms may be useful for differential diagnosis and treatment planning.
format Online
Article
Text
id pubmed-10289868
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-102898682023-06-24 Distinct and shared neuropsychiatric phenotypes in FTLD-tauopathies Keszycki, Rachel Kawles, Allegra Minogue, Grace Zouridakis, Antonia Macomber, Alyssa Gill, Nathan Vu, My Zhang, Hui Coventry, Christina Rogalski, Emily Weintraub, Sandra Mesulam, M-Marsel Geula, Changiz Gefen, Tamar Front Aging Neurosci Aging Neuroscience Frontotemporal lobar degeneration (FTLD) with tau pathology (FTLD-tau) commonly causes dementia syndromes that include primary progressive aphasia (PPA) and behavioral variant frontotemporal dementia (bvFTD). Cognitive decline in PPA and bvFTD is often accompanied by debilitating neuropsychiatric symptoms. In 44 participants with PPA or bvFTD due to autopsy-confirmed FTLD-tau, we characterized neuropsychiatric symptoms at early and late disease stages and determined whether the presence of certain symptoms predicted a specific underlying FTLD-tauopathy. Participants completed annual research visits at the Northwestern University Alzheimer’s Disease Research Center. All participants had an initial Global Clinical Dementia Rating (CDR) Scale score ≤ 2, and neuropsychiatric symptoms were evaluated via the Neuropsychiatric Inventory-Questionnaire (NPI-Q). We assessed the frequency of neuropsychiatric symptoms across all participants at their initial and final visits and performed logistic regression to determine whether symptoms predicted a specific FTLD-tau pathologic diagnosis. Across the FTLD-tau cohort, irritability and apathy were most frequently endorsed at initial and final visits, respectively, whereas psychosis was highly uncommon at both timepoints. Irritability at initial visit predicted greater odds of a 4-repeat compared to a 3-repeat tauopathy (OR = 3.95, 95% CI = 1.10–15.83, p < 0.05). Initial sleep disturbance predicted greater odds of progressive supranuclear palsy (PSP) compared to other FTLD-tau subtypes (OR = 10.68, 95% CI = 2.05–72.40, p < 0.01). Appetite disturbance at final evaluation predicted lower odds of PSP (OR = 0.15, 95% CI = 0.02–0.74, p < 0.05). Our findings suggest that characterization of neuropsychiatric symptoms can aid in the prediction of underlying FTLD-tauopathies. Given considerable pathologic heterogeneity underlying dementias, neuropsychiatric symptoms may be useful for differential diagnosis and treatment planning. Frontiers Media S.A. 2023-06-09 /pmc/articles/PMC10289868/ /pubmed/37358954 http://dx.doi.org/10.3389/fnagi.2023.1164581 Text en Copyright © 2023 Keszycki, Kawles, Minogue, Zouridakis, Macomber, Gill, Vu, Zhang, Coventry, Rogalski, Weintraub, Mesulam, Geula and Gefen. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Aging Neuroscience
Keszycki, Rachel
Kawles, Allegra
Minogue, Grace
Zouridakis, Antonia
Macomber, Alyssa
Gill, Nathan
Vu, My
Zhang, Hui
Coventry, Christina
Rogalski, Emily
Weintraub, Sandra
Mesulam, M-Marsel
Geula, Changiz
Gefen, Tamar
Distinct and shared neuropsychiatric phenotypes in FTLD-tauopathies
title Distinct and shared neuropsychiatric phenotypes in FTLD-tauopathies
title_full Distinct and shared neuropsychiatric phenotypes in FTLD-tauopathies
title_fullStr Distinct and shared neuropsychiatric phenotypes in FTLD-tauopathies
title_full_unstemmed Distinct and shared neuropsychiatric phenotypes in FTLD-tauopathies
title_short Distinct and shared neuropsychiatric phenotypes in FTLD-tauopathies
title_sort distinct and shared neuropsychiatric phenotypes in ftld-tauopathies
topic Aging Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10289868/
https://www.ncbi.nlm.nih.gov/pubmed/37358954
http://dx.doi.org/10.3389/fnagi.2023.1164581
work_keys_str_mv AT keszyckirachel distinctandsharedneuropsychiatricphenotypesinftldtauopathies
AT kawlesallegra distinctandsharedneuropsychiatricphenotypesinftldtauopathies
AT minoguegrace distinctandsharedneuropsychiatricphenotypesinftldtauopathies
AT zouridakisantonia distinctandsharedneuropsychiatricphenotypesinftldtauopathies
AT macomberalyssa distinctandsharedneuropsychiatricphenotypesinftldtauopathies
AT gillnathan distinctandsharedneuropsychiatricphenotypesinftldtauopathies
AT vumy distinctandsharedneuropsychiatricphenotypesinftldtauopathies
AT zhanghui distinctandsharedneuropsychiatricphenotypesinftldtauopathies
AT coventrychristina distinctandsharedneuropsychiatricphenotypesinftldtauopathies
AT rogalskiemily distinctandsharedneuropsychiatricphenotypesinftldtauopathies
AT weintraubsandra distinctandsharedneuropsychiatricphenotypesinftldtauopathies
AT mesulammmarsel distinctandsharedneuropsychiatricphenotypesinftldtauopathies
AT geulachangiz distinctandsharedneuropsychiatricphenotypesinftldtauopathies
AT gefentamar distinctandsharedneuropsychiatricphenotypesinftldtauopathies